Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size & Outlook
Middle East & Africa oral solid dosage contract manufacturing market, 2018-2030 (US$M)
Related Markets
MEA oral solid dosage contract manufacturing market highlights
- The MEA oral solid dosage contract manufacturing market generated a revenue of USD 1,386.9 million in 2023.
- The market is expected to grow at a CAGR of 3.3% from 2024 to 2030.
- In terms of segment, tablets was the largest revenue generating product in 2023.
- Capsules is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 1,386.9 million |
| Market revenue in 2030 | USD 1,740.0 million |
| Growth rate | 3.3% (CAGR from 2023 to 2030) |
| Largest segment | Tablets |
| Fastest growing segment | Capsules |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tablets, Capsules, Powders, Granules |
| Key market players worldwide | Catalent Inc, Lonza Group Ltd, Boehringer Ingelheim, Jubilant Pharmova, Novacyt SA, Thermo Fisher Scientific Inc, Recipharm, CordenPharma, Siegfried Holding AG, Piramal Pharma Solutions, AbbVie Inc |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.8% of the global oral solid dosage contract manufacturing market in 2023.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 19,479.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oral Solid Dosage Contract Manufacturing Market Scope
Oral Solid Dosage Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa oral solid dosage contract manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oral solid dosage contract manufacturing market will help companies and investors design strategic landscapes.
Tablets was the largest segment with a revenue share of 33.42% in 2023. Horizon Databook has segmented the Middle East & Africa oral solid dosage contract manufacturing market based on tablets, capsules, powders, granules covering the revenue growth of each sub-segment from 2018 to 2030.
Middle Eastern countries such as South Africa, Saudi Arabia, the United Arab Emirates (UAE), and Kuwait are prospering economies. The oral solid dosage contract manufacturing market in the MEA region is likely to grow steadily in the coming years.
The increasing burden of diseases and demand for drugs are major factors contributing to the growth of the market. Besides, the growing number of clinical trials is anticipated to boost the market growth. For instance, the WHO International Clinical Trials Registry Platform (ICTRP) reports 861 clinical trials as registered in Africa in 2022.
Reasons to subscribe to Middle East & Africa oral solid dosage contract manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa oral solid dosage contract manufacturing market databook
-
Our clientele includes a mix of oral solid dosage contract manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa oral solid dosage contract manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa oral solid dosage contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA oral solid dosage contract manufacturing market size, by country, 2018-2030 (US$M)
Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
